| Literature DB >> 29976617 |
Rocky L Baker1, Braxton L Jamison2, Timothy A Wiles2, Robin S Lindsay3, Gene Barbour2, Brenda Bradley2, Thomas Delong2, Rachel S Friedman3, Maki Nakayama4, Kathryn Haskins1.
Abstract
We recently established that hybrid insulin peptides (HIPs), formed in islet β-cells by fusion of insulin C-peptide fragments to peptides of chromogranin A or islet amyloid polypeptide, are ligands for diabetogenic CD4 T-cell clones. The goal of this study was to investigate whether HIP-reactive T cells were indicative of ongoing autoimmunity. MHC class II tetramers were used to investigate the presence, phenotype, and function of HIP-reactive and insulin-reactive T cells in NOD mice. Insulin-reactive T cells encounter their antigen early in disease, but they express FoxP3 and therefore may contribute to immune regulation. In contrast, HIP-reactive T cells are proinflammatory and highly diabetogenic in an adoptive transfer model. Because the frequency of antigen-experienced HIP-reactive T cells increases over progression of disease, they may serve as biomarkers of autoimmune diabetes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29976617 PMCID: PMC6110316 DOI: 10.2337/db18-0200
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461